```html

Proteinuria: A Complete Patient‑Friendly Guide

Overview

Proteinuria (also spelled proteinuría) is the presence of an abnormal amount of protein in the urine. Normally, the kidneys filter blood, retaining proteins while allowing waste products to pass into the urine. When the filtering units (glomeruli) are damaged or the urinary tract is affected, protein can leak into the urine.

Proteinuria can be transient (temporary) due to factors such as fever, intense exercise, or dehydration, or it can be persistent, signaling an underlying kidney disease or systemic condition.

Who it affects

• Adults over 50 years – prevalence rises to 13‑15 % in community‑based studies (NHANES, 2020).
• People with diabetes (type 1 or type 2) – up to 40 % develop proteinuria within 10 years of diagnosis.
• Patients with hypertension, cardiovascular disease, or a family history of kidney disease.
• Children with congenital kidney abnormalities or certain infections (e.g., streptococcal pharyngitis).

Overall, proteinuria is one of the earliest detectable signs of chronic kidney disease (CKD), affecting an estimated 10‑15 % of the world’s population (World Health Organization, 2022).

Symptoms

Many individuals with early or mild proteinuria have no noticeable symptoms. When symptoms do appear, they may be subtle or related to the underlying condition.

• Foam or frothy urine – protein creates a soap‑like texture.
• Swelling (edema) – especially around the eyes, ankles, or feet due to fluid retention.
• Weight gain – from fluid accumulation.
• Decreased urine output or a feeling of incomplete bladder emptying.
• Fatigue or weakness – a consequence of low serum albumin.
• High blood pressure – often co‑exists with kidney damage.
• Loss of appetite, nausea, or vomiting – more common in advanced kidney disease.
• Dark or “tea‑colored” urine – may indicate concurrent hematuria.

Because many of these signs overlap with other illnesses, laboratory testing is essential for an accurate diagnosis.

Causes and Risk Factors

Proteinuria is a symptom, not a disease itself. The underlying cause can be renal (originating inside the kidney) or extrarenal.

Renal Causes

• Glomerulonephritis – inflammation of the glomeruli (e.g., IgA nephropathy, lupus nephritis).
• Diabetic nephropathy – high blood glucose damages glomerular filtration barriers.
• Hypertensive nephrosclerosis – chronic high blood pressure leads to scarring.
• Focal segmental glomerulosclerosis (FSGS) – scarring in parts of some glomeruli.
• Polycystic kidney disease – cysts compress functional tissue.
• Acute kidney injury (AKI) – may cause temporary protein leakage.

Extrarenal Causes

• Orthostatic (postural) proteinuria – protein appears only when standing; common in adolescents.
• Infections – urinary tract infections, hepatitis B/C, HIV.
• Medications – non‑steroidal anti‑inflammatory drugs (NSAIDs), certain antibiotics (e.g., vancomycin), and some chemotherapeutic agents.
• Systemic diseases – multiple myeloma, amyloidosis.
• Pregnancy – pre‑eclampsia can cause sudden proteinuria.

Risk Factors

• Age > 45 years
• Uncontrolled diabetes or hypertension
• Obesity (BMI ≥ 30 kg/m²)
• Family history of CKD or kidney disease
• Smoking
• High‑protein diets or excessive protein supplements (rarely cause true pathology but may transiently increase urinary protein)

Diagnosis

Detecting proteinuria begins with a simple urine test, but a thorough work‑up is required to determine the cause and severity.

Screening Tests

• Urine dipstick – provides a semi‑quantitative result (negative, trace, +1 to +4). Positive dipstick prompts confirmatory testing.
• Spot urine protein‑to‑creatinine ratio (UPCR) – estimates 24‑hour protein excretion from a single sample; values > 0.3 g/g are abnormal.
• 24‑hour urine collection – gold standard for measuring total protein loss; > 150 mg/day is considered proteinuria, > 3.5 g/day denotes nephrotic‑range proteinuria.

Blood Tests

• Serum creatinine & eGFR – assess kidney function.
• Serum albumin – low levels suggest nephrotic syndrome.
• Blood glucose, HbA1c – screen for diabetes.
• Lipid panel – dyslipidemia often accompanies nephrotic syndrome.
• Autoimmune panels (ANA, anti‑dsDNA, complement levels) if glomerulonephritis is suspected.

**Imaging & Specialized Tests**

• Renal ultrasound – evaluates kidney size, cysts, obstruction.
• Kidney biopsy – indicated when the cause remains unclear after non‑invasive testing; provides definitive histologic diagnosis.

Guidelines from the Kidney Disease Outcomes Quality Initiative (KDOQI) and the CDC recommend confirming abnormal dipstick results with either UPCR or a 24‑hour collection before initiating treatment.

Treatment Options

Treatment is directed at three goals: (1) stop or slow further kidney damage, (2) control underlying disease, and (3) manage symptoms.

Medications

• Angiotensin‑Converting Enzyme (ACE) inhibitors (e.g., lisinopril, enalapril) – reduce intraglomerular pressure and protein leakage.
• Angiotensin II Receptor Blockers (ARBs) (e.g., losartan, valsartan) – alternative for patients intolerant to ACE inhibitors.
• Diuretics (e.g., furosemide) – relieve edema.
• Statins – lower cardiovascular risk, often indicated in nephrotic syndrome.
• Immunosuppressive agents (e.g., corticosteroids, cyclophosphamide, mycophenolate) – used for immune‑mediated glomerulonephritis.
• Anticoagulation – considered in severe nephrotic syndrome with high thrombotic risk.

Procedural Interventions

• Renal biopsy – diagnostic, may guide targeted therapy.
• Plasmapheresis – used in certain rapidly progressive glomerulonephritides.
• Dialysis or kidney transplantation – reserved for end‑stage renal disease (ESRD).

Lifestyle & Dietary Modifications

• Low‑sodium diet – ≤ 2 g/day to control blood pressure and edema.
• Moderate protein intake – 0.8 g/kg ideal body weight/day for CKD; higher intake may be needed in children or pregnant women.
• Blood pressure control – target <130/80 mm Hg (ACC/AHA 2023).
• Glycemic control – aim for HbA1c < 7 % (American Diabetes Association).
• Quit smoking, limit alcohol, and engage in regular aerobic activity (≥150 min/week).

Living with Proteinuria

Managing proteinuria is a partnership between you, your primary care provider, and a nephrologist.

• Regular monitoring – check urine protein levels every 3‑6 months or as directed.
• Medication adherence – never skip ACE‑I/ARB doses; set reminders.
• Track fluid status – weigh yourself daily; a sudden gain of > 2 kg may indicate fluid retention.
• Healthy eating – use a renal‑dietitian to plan meals that meet protein and sodium goals.
• Vaccinations – stay up to date on influenza, pneumococcal, hepatitis B, and COVID‑19 vaccines (CDC recommendations).
• Stress management – chronic disease can be emotionally taxing; consider counseling or support groups.

Prevention

While some causes (genetic) cannot be prevented, many risk factors are modifiable.

• Maintain a healthy weight (BMI 18‑24 kg/m²).
• Control blood pressure and blood sugar aggressively.
• Limit salt intake to <2 g/day (≈ ½ tsp).
• Avoid over‑the‑counter NSAIDs or use them only under physician guidance.
• Stay hydrated but avoid excessive fluid restriction without medical advice.
• Screen high‑risk individuals (diabetics, hypertensives) annually for proteinuria.

Complications

If proteinuria remains untreated, it can progress to chronic kidney disease and eventually end‑stage renal disease.

• Nephrotic syndrome – massive protein loss (>3.5 g/day) leading to severe edema, hyperlipidemia, and hypercoagulability.
• Hypertension – worsening renal perfusion creates a vicious cycle.
• Cardiovascular disease – proteinuria is an independent risk factor for myocardial infarction and stroke.
• Acute kidney injury – superimposed episodes can accelerate CKD.
• Thromboembolic events – especially in nephrotic syndrome (e.g., deep‑vein thrombosis, pulmonary embolism).
• Infections – loss of immunoglobulins in urine can increase susceptibility.

When to Seek Emergency Care

---

Sources: Mayo Clinic, National Kidney Foundation (KDOQI), Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), World Health Organization (WHO), Cleveland Clinic, American College of Cardiology (ACC) 2023 Hypertension Guidelines, American Diabetes Association 2024 Standards.

```